|
NET1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.626300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.271900E-02 |
| Normal-vs-Stage2 |
1.21929999985504E-07 |
| Normal-vs-Stage3 |
8.089000E-01 |
| Normal-vs-Stage4 |
4.282200E-01 |
| Stage1-vs-Stage2 |
5.78900000000049E-05 |
| Stage1-vs-Stage3 |
7.276000E-02 |
| Stage1-vs-Stage4 |
4.236200E-02 |
| Stage2-vs-Stage3 |
1.18890000000427E-06 |
| Stage2-vs-Stage4 |
2.4503000000009E-05 |
| Stage3-vs-Stage4 |
5.648400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.169800E-01 |
| Normal-vs-AfricanAmerican |
1.833050E-01 |
| Normal-vs-Asian |
4.794000E-01 |
| Caucasian-vs-AfricanAmerican |
2.386100E-02 |
| Caucasian-vs-Asian |
9.025000E-01 |
| AfricanAmerican-vs-Asian |
1.157030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.268400E-01 |
| Normal-vs-Female |
4.524000E-02 |
| Male-vs-Female |
1.683830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.345200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.691500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.357830E-01 |
| Normal-vs-Age(81-100Yrs) |
2.694400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.362000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.243400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.882500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.693600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.935800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.995600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.675700E-02 |
| Classical-VS-Follicular |
1.63180580159406E-12 |
| Classical-VS-Other |
8.876600E-01 |
| Classical-VS-Normal |
9.817800E-01 |
| Tall-VS-Follicular |
1.42390000001935E-06 |
| Tall-VS-Other |
3.347000E-01 |
| Tall-VS-Normal |
7.210400E-02 |
| Follicular-VS-Other |
1.565960E-01 |
| Follicular-VS-Normal |
2.15010009796401E-10 |
| Other-VS-Normal |
9.157600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.038430E-04 |
| Normal-vs-N1 |
4.886400E-01 |
| N0-vs-N1 |
3.248000E-02 |
|
|
